Recall of eight heartburn medications sparks concern about a knock-on effect
Pharmacists may face shortages of heartburn medications as a result of a TGA recall of a number of products that contain ranitidine.
The regulator has named eight branded and generic tablets and liquids that have been recalled as a result of contamination with a probable carcinogen.
The TGA has advised pharmacists and doctors to consider alternative medications, such as another H2 receptor antagonist or proton pump inhibitors.
However, Pharmacy Guild Victoria president Anthony Tassone says the